(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ALDH9A1 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine affects expression ISO RGD:68604 6480464 1, 2-Dimethylhydrazine affects the expression of ALDH9A1 mRNA CTD PMID:22206623 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:68603 6480464 Metribolone results in increased expression of ALDH9A1 protein CTD PMID:17152098 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20056577 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALDH9A1 mRNA CTD PMID:21215274 , PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ALDH9A1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ALDH9A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:68604 6480464 [Tetrachlorodibenzodioxin co-treated with AHR protein mutant form] results in decreased expression of ALDH9A1 mRNA CTD PMID:22496397 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ALDH9A1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:68603 6480464 Lactic Acid results in increased expression of ALDH9A1 mRNA CTD PMID:30851411 3-chloropropane-1,2-diol affects expression EXP 6480464 alpha-Chlorohydrin analog affects the expression of ALDH9A1 protein CTD PMID:26072098 , PMID:26597043 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of ALDH9A1 protein CTD PMID:26072098 4,4'-sulfonyldiphenol increases expression ISO RGD:68603 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ALDH9A1 protein CTD PMID:34186270 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ALDH9A1 mRNA CTD PMID:24780913 acetaldehyde increases oxidation ISO RGD:68603 6480464 ALDH9A1 protein results in increased oxidation of Acetaldehyde CTD PMID:18940187 acetaldehyde multiple interactions ISO RGD:68604 6480464 [CGA protein results in increased abundance of Acetaldehyde] which results in increased expression of ALDH9A1 mRNA CTD PMID:22285649 all-trans-retinoic acid decreases expression ISO RGD:68603 6480464 Tretinoin results in decreased expression of ALDH9A1 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ALDH9A1 mRNA CTD PMID:16483693 arecoline decreases expression ISO RGD:68603 6480464 Arecoline results in decreased expression of ALDH9A1 mRNA CTD PMID:17682004 arsenite(3-) multiple interactions ISO RGD:68603 6480464 arsenite promotes the reaction [G3BP1 protein binds to ALDH9A1 mRNA] CTD PMID:32406909 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA CTD PMID:33854195 benzo[a]pyrene increases expression ISO RGD:68604 6480464 Benzo(a)pyrene results in increased expression of ALDH9A1 mRNA CTD PMID:20127859 benzo[a]pyrene multiple interactions ISO RGD:68603 6480464 [Soot co-treated with Benzo(a)pyrene] results in decreased expression of ALDH9A1 protein modified form CTD PMID:24464499 bis(2-ethylhexyl) phthalate increases expression ISO RGD:68604 6480464 Diethylhexyl Phthalate results in increased expression of ALDH9A1 mRNA CTD PMID:17998271 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ALDH9A1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:68603 6480464 bisphenol A results in decreased expression of ALDH9A1 protein CTD PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ALDH9A1 mRNA CTD PMID:30816183 more ... Bisphenol B increases expression ISO RGD:68603 6480464 bisphenol B results in increased expression of ALDH9A1 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:68603 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of ALDH9A1 gene CTD PMID:31601247 bisphenol F increases expression ISO RGD:68603 6480464 bisphenol F results in increased expression of ALDH9A1 protein CTD PMID:34186270 bromobenzene affects binding EXP 6480464 bromobenzene metabolite binds to ALDH9A1 protein CTD PMID:17305373 cadmium atom multiple interactions ISO RGD:68603 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ALDH9A1 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO RGD:68603 6480464 Cadmium Chloride results in increased expression of ALDH9A1 protein CTD PMID:24527689 cadmium dichloride multiple interactions ISO RGD:68603 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ALDH9A1 mRNA CTD PMID:35301059 caffeine increases expression EXP 6480464 Caffeine results in increased expression of ALDH9A1 mRNA CTD PMID:20864626 cannabidiol decreases expression ISO RGD:68603 6480464 Cannabidiol results in decreased expression of ALDH9A1 protein CTD PMID:34122009 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA CTD PMID:33854195 choline multiple interactions ISO RGD:68604 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ALDH9A1 gene CTD PMID:20938992 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] inhibits the reaction [Folic Acid deficiency results in increased expression of ALDH9A1 protein] CTD PMID:19566968 ciprofibrate increases expression ISO RGD:68604 6480464 ciprofibrate results in increased expression of ALDH9A1 mRNA CTD PMID:17998271 cisplatin increases expression ISO RGD:68603 6480464 Cisplatin results in increased expression of ALDH9A1 mRNA CTD PMID:27594783 clofibrate multiple interactions ISO RGD:68604 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ALDH9A1 mRNA more ... CTD PMID:17585979 , PMID:22496397 clofibrate increases expression ISO RGD:68604 6480464 Clofibrate results in increased expression of ALDH9A1 mRNA CTD PMID:22496397 clofibric acid increases expression ISO RGD:68604 6480464 Clofibric Acid results in increased expression of ALDH9A1 mRNA CTD PMID:17998271 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ALDH9A1 mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ALDH9A1 mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:68603 6480464 Copper Sulfate results in decreased expression of ALDH9A1 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:68603 6480464 Cyclosporine results in decreased expression of ALDH9A1 mRNA CTD PMID:20106945 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ALDH9A1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:68604 6480464 Dibutyl Phthalate results in decreased expression of ALDH9A1 mRNA CTD PMID:17361019 , PMID:21266533 doxorubicin decreases expression ISO RGD:68603 6480464 Doxorubicin results in decreased expression of ALDH9A1 mRNA CTD PMID:29803840 fenpyroximate decreases expression ISO RGD:68603 6480464 fenpyroximate results in decreased expression of ALDH9A1 mRNA CTD PMID:33512557 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ALDH9A1 protein CTD PMID:17311803 folic acid multiple interactions ISO RGD:68604 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ALDH9A1 gene CTD PMID:20938992 folic acid increases expression EXP 6480464 Folic Acid deficiency results in increased expression of ALDH9A1 protein CTD PMID:19566968 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] inhibits the reaction [Folic Acid deficiency results in increased expression of ALDH9A1 protein] CTD PMID:19566968 fulvestrant multiple interactions ISO RGD:68603 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of ALDH9A1 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ALDH9A1 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of ALDH9A1 mRNA CTD PMID:24136188 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA CTD PMID:33854195 hydralazine multiple interactions ISO RGD:68603 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ALDH9A1 mRNA CTD PMID:17183730 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA CTD PMID:33854195 isobutanol multiple interactions ISO RGD:68603 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ALDH9A1 mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:68603 6480464 Ivermectin results in decreased expression of ALDH9A1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:68604 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ALDH9A1 gene CTD PMID:20938992 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] inhibits the reaction [Folic Acid deficiency results in increased expression of ALDH9A1 protein] CTD PMID:19566968 lead(0) decreases expression ISO RGD:68603 6480464 Lead results in decreased expression of ALDH9A1 mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:68603 6480464 Lead results in decreased expression of ALDH9A1 mRNA CTD PMID:19921347 lipopolysaccharide multiple interactions ISO RGD:68603 6480464 [Lipopolysaccharides co-treated with resveratrol] results in increased expression of ALDH9A1 mRNA CTD PMID:26667767 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of ALDH9A1 mRNA CTD PMID:30467583 methoxyacetic acid increases expression EXP 6480464 methoxyacetic acid results in increased expression of ALDH9A1 mRNA CTD PMID:20864626 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of ALDH9A1 mRNA CTD PMID:20864626 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of ALDH9A1 protein CTD PMID:22430071 Monobutylphthalate increases expression EXP 6480464 monobutyl phthalate results in increased expression of ALDH9A1 mRNA CTD PMID:20864626 ozone increases expression EXP 6480464 Ozone results in increased expression of ALDH9A1 protein CTD PMID:33146391 paclitaxel increases expression ISO RGD:68603 6480464 Paclitaxel results in increased expression of ALDH9A1 protein CTD PMID:15907983 paracetamol multiple interactions ISO RGD:68604 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ALDH9A1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ALDH9A1 mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:68603 6480464 Acetaminophen results in decreased expression of ALDH9A1 mRNA CTD PMID:29067470 perfluorododecanoic acid decreases expression EXP 6480464 perfluorododecanoic acid results in decreased expression of ALDH9A1 protein CTD PMID:26168851 perfluorooctane-1-sulfonic acid affects expression ISO RGD:68604 6480464 perfluorooctane sulfonic acid affects the expression of ALDH9A1 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:68604 6480464 perfluorooctane sulfonic acid results in increased expression of ALDH9A1 mRNA CTD PMID:20936131 perfluorooctanoic acid affects expression ISO RGD:68604 6480464 perfluorooctanoic acid affects the expression of ALDH9A1 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression ISO RGD:68603 6480464 perfluorooctanoic acid results in increased expression of ALDH9A1 protein CTD PMID:26879310 perfluorooctanoic acid multiple interactions ISO RGD:68604 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of ALDH9A1 mRNA] CTD PMID:18467677 perfluorooctanoic acid increases expression ISO RGD:68604 6480464 perfluorooctanoic acid results in increased expression of ALDH9A1 mRNA CTD PMID:17681415 , PMID:18467677 phenobarbital decreases expression ISO RGD:68603 6480464 Phenobarbital results in decreased expression of ALDH9A1 protein CTD PMID:28541575 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of ALDH9A1 mRNA CTD PMID:33945839 picoxystrobin decreases expression ISO RGD:68603 6480464 picoxystrobin results in decreased expression of ALDH9A1 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:68604 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of ALDH9A1 mRNA] CTD PMID:17950772 , PMID:18467677 pirinixic acid increases expression ISO RGD:68604 6480464 pirinixic acid results in increased expression of ALDH9A1 mRNA CTD PMID:17950772 more ... quercetin increases expression EXP 6480464 Quercetin results in increased expression of ALDH9A1 mRNA CTD PMID:21565894 rac-lactic acid increases expression ISO RGD:68603 6480464 Lactic Acid results in increased expression of ALDH9A1 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:68603 6480464 [Lipopolysaccharides co-treated with Resveratrol] results in increased expression of ALDH9A1 mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of ALDH9A1 mRNA CTD PMID:23557933 , PMID:26667767 rotenone decreases expression ISO RGD:68603 6480464 Rotenone results in decreased expression of ALDH9A1 mRNA CTD PMID:33512557 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ALDH9A1 protein CTD PMID:29459688 sunitinib decreases expression ISO RGD:68603 6480464 Sunitinib results in decreased expression of ALDH9A1 mRNA CTD PMID:31533062 tacrolimus hydrate decreases expression ISO RGD:68604 6480464 Tacrolimus results in decreased expression of ALDH9A1 mRNA CTD PMID:25270620 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ALDH9A1 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ALDH9A1 mRNA CTD PMID:31150632 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA CTD PMID:33854195 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ALDH9A1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:68604 6480464 titanium dioxide results in increased expression of ALDH9A1 mRNA CTD PMID:29264374 valproic acid multiple interactions ISO RGD:68603 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ALDH9A1 mRNA CTD PMID:17183730 valproic acid increases expression ISO RGD:68603 6480464 Valproic Acid results in increased expression of ALDH9A1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:68603 6480464 Valproic Acid affects the expression of ALDH9A1 mRNA CTD PMID:25979313 valproic acid affects expression ISO RGD:68604 6480464 Valproic Acid affects the expression of ALDH9A1 mRNA CTD PMID:17292431 vancomycin increases expression ISO RGD:68604 6480464 Vancomycin results in increased expression of ALDH9A1 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ALDH9A1 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ALDH9A1 mRNA CTD PMID:23869203 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of ALDH9A1 gene CTD PMID:31079544